CHICAGO (Reuters) - A new process to extract and copy the essential elements of cells that make human antibodies has provided a shortcut to making targeted, infection-fighting proteins known as monoclonal antibodies, U.S. researchers said on Wednesday.
The process allowed them to make influenza-specific antibodies in as little as a month, and they said the discovery could lead new treatments for other infectious diseases such as hepatitis C, pneumococcal pneumonia or anthrax.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!